HK2 inhibitor, 3-bromopyruvate (3-BP), in addition to disrupting ATP production, significantly impaired autophagy and induced apoptosis, which was demonstrated in MM cells (Ikeda et al., 2020). This evidence concerns the gene HK2 and Miyoshi myopathy.